News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kemia, Inc. Announces Initiation Of Phase I Trials For Oral Anti-Inflammatory


10/19/2005 5:13:19 PM

SAN DIEGO--(BUSINESS WIRE)--Oct. 6, 2005--Kemia announced today that the company has initiated Phase I clinical trials with KC706, an oral anti-inflammatory. "We are particularly proud that this new drug candidate was conceived within Kemia and has reached the clinic in a relatively short period of time," said Lew Shuster, Kemia's CEO. "Advancing this program to the clinic is an important milestone for the company and a validation of our team's drug discovery and development abilities."

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES